JPS53130440A - Novel pharmaceutical composition having obuect to treat especially functional disorder of brain - Google Patents

Novel pharmaceutical composition having obuect to treat especially functional disorder of brain

Info

Publication number
JPS53130440A
JPS53130440A JP4135578A JP4135578A JPS53130440A JP S53130440 A JPS53130440 A JP S53130440A JP 4135578 A JP4135578 A JP 4135578A JP 4135578 A JP4135578 A JP 4135578A JP S53130440 A JPS53130440 A JP S53130440A
Authority
JP
Japan
Prior art keywords
obuect
brain
pharmaceutical composition
novel pharmaceutical
functional disorder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP4135578A
Other languages
Japanese (ja)
Other versions
JPS627167B2 (en
Inventor
Maza Mishieru
Omo Andore
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Publication of JPS53130440A publication Critical patent/JPS53130440A/en
Publication of JPS627167B2 publication Critical patent/JPS627167B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP4135578A 1977-04-12 1978-04-10 Novel pharmaceutical composition having obuect to treat especially functional disorder of brain Granted JPS53130440A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7710906A FR2387035A1 (en) 1977-04-12 1977-04-12 NEW MEDICINAL PRODUCT INTENDED IN PARTICULAR FOR THE TREATMENT OF FUNCTIONAL CEREBRAL DISORDERS

Publications (2)

Publication Number Publication Date
JPS53130440A true JPS53130440A (en) 1978-11-14
JPS627167B2 JPS627167B2 (en) 1987-02-16

Family

ID=9189287

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4135578A Granted JPS53130440A (en) 1977-04-12 1978-04-10 Novel pharmaceutical composition having obuect to treat especially functional disorder of brain

Country Status (10)

Country Link
JP (1) JPS53130440A (en)
BE (1) BE865891A (en)
DE (1) DE2815878C2 (en)
FR (1) FR2387035A1 (en)
GB (1) GB1556851A (en)
GR (1) GR72116B (en)
IL (1) IL54462A0 (en)
IT (1) IT1102581B (en)
NL (1) NL7803895A (en)
PT (1) PT67885B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4511557A (en) * 1981-08-24 1985-04-16 Gauri Kailash Kumar Pharmaceutical composition
FI81258C (en) * 1982-02-01 1990-10-10 Sandoz Ag FOERFARANDE FOER FRAMSTAELLNING AV EN PHARMACEUTISK KOMPOSITION FOER NASAL ADMINISTRATION.
GB8418430D0 (en) * 1984-07-19 1984-08-22 Beecham Wuelfing Gmbh & Co Kg Treatment
GB8621869D0 (en) * 1986-09-11 1986-10-15 Beecham Group Plc Treatment

Also Published As

Publication number Publication date
GR72116B (en) 1983-09-15
IT7848852A0 (en) 1978-04-11
FR2387035B1 (en) 1980-03-21
JPS627167B2 (en) 1987-02-16
IT1102581B (en) 1985-10-07
DE2815878C2 (en) 1986-10-09
FR2387035A1 (en) 1978-11-10
NL7803895A (en) 1978-10-16
BE865891A (en) 1978-10-11
IL54462A0 (en) 1978-07-31
PT67885A (en) 1978-05-01
DE2815878A1 (en) 1978-10-19
GB1556851A (en) 1979-11-28
PT67885B (en) 1980-04-07

Similar Documents

Publication Publication Date Title
JPS53136521A (en) Composition of treating multiplicable skin disease
JPS53136523A (en) Application of calnitine derivatives to medicine
GB1543157A (en) Treatment of fibres
JPS5462898A (en) Improvement of distributor
JPS5461994A (en) Improvement of distributor
GB2003920B (en) Composition for lubricating treatment of synthetic fibres
ZA763155B (en) Improvements in or relating to compounds having a physiological action on the nervous system of the human body and compositions containing them
JPS5459281A (en) Purification of pseudomonic acid
GB1544718A (en) Method for attachment of one member to another
PT67743A (en) Preparation of therapeutic agents
JPS5733587A (en) Precipitating of palladium to tobacco
JPS53130440A (en) Novel pharmaceutical composition having obuect to treat especially functional disorder of brain
ZA761825B (en) Preparation of therapeutic compounds
GB2001625B (en) Process for preparation of 3-acylamino-4-homoisotwistane
JPS5484060A (en) Treatment of raw *wakame* by using chlorella extract
JPS5441332A (en) Treating composition of sickle shaped erythrocyte disease
JPS53144537A (en) Novel derivative of ppacetoamtde phenol process for preparing same and application to medical treatment thereof
DE2861567D1 (en) Addition salts of substituted aralkylamins and therapeutic composition containing them
IT1133829B (en) THERAPEUTIC COMPOSITION TO TREAT GLAUCOMA
JPS54135230A (en) Use of ciss*3*3*5**trymethyl cyclohexanol to treat bile disorder
GB1549524A (en) Composition for the treatment of cancer
GB2002725B (en) Treatment of minestone
JPS5449301A (en) Preparation of collangen containing no pyrogen
JPS5438665A (en) Improvement of nighttsoil treatment system
JPS5439955A (en) Improvement of nighttsoil treatment system